GlassScriptPhysician profile
Holly G Coleman
NPI 1720163868
$1,597.50
in general payments reported to CMS, 2019-2025
26 companies · $55.11 in 2025
The $55.11 reported for 2025 was less than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $421 · 2020: $291 · 2021: $281 · 2022: $215 · 2023: $123 · 2024: $212 · 2025: $55.11.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $390.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $389.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $219.68 | 2019-2023 | Orilissa |
| Therapeuticsmd, INC. | $206.12 | 2019-2021 | |
| Mayne Pharma Commercial LLC | $144.66 | 2021-2023 | |
| Lupin INC. | $131.62 | 2019-2021 | |
| Astellas Pharma US INC | $125.28 | 2023-2024 | Veozah, Myrbetriq |
| Exact Sciences Corporation | $97.02 | 2023-2025 | Cologuard Collection Kit |
| Endo Pharmaceuticals INC. | $80.21 | 2019-2020 | |
| Millicent US INC | $77.44 | 2020-2021 | |
| Novo Nordisk INC | $51.06 | 2019-2024 | |
| Vertical Pharmaceuticals, LLC | $51.03 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $48.61 | 2019 | |
| Organon LLC | $41.05 | 2022-2024 | |
| Dysis Medical, INC. | $37.30 | 2022 | |
| Currax Pharmaceuticals LLC | $34.36 | 2023-2025 | Contrave, Onzetra Xsail |
| Karl Storz Endoscopy-America | $31.87 | 2023 | N.A. |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $25.76 | 2022 | |
| Avion Pharmaceuticals | $24.90 | 2021-2022 | |
| Coopersurgical, INC. | $24.69 | 2024 | Endosee |
| Merck Sharp & Dohme LLC | $23.92 | 2020 | |
| Duchesnay USA Incorporated | $22.50 | 2019 | |
| Nalpropion Pharmaceuticals LLC | $22.43 | 2019 | |
| Agile Therapeutics, INC. | $19.38 | 2021 | |
| Allergan, INC. | $15.89 | 2019 | |
| Echosens North America, INC. | $14.71 | 2022 | |
| Scynexis, INC. | $14.13 | 2022 | |
| Virtus Pharmaceuticals LLC | $11.88 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Holly Coleman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.